Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection.

Mind long COVID: Psychiatric sequelae of SARS-CoV-2 infection.
复制标题

DOI:
10.1016/j.euroneuro.2021.04.019
复制
发表时间:
2021-08
期刊:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
影响因子:
--
通讯作者:
Vieta E
Vieta E
中科院分区:
其他
文献类型:
--
作者:
Llach CD;Vieta E

文献摘要

参考文献

被引文献

相似文献

美国著名科幻作家、小说《沙丘》的作者弗兰克·赫伯特曾说过“没有真正的结局,只是故事停止的地方”。最近,我们科学界逐渐了解到,这句话的含义对于受 COVID-19 影响的患者具有特殊的意义。事实上,出院远非故事的结束,通常只代表了这个过程的开始。一系列身体和精神症状可能会继续存在,也可能会在事后出现,形成一种多系统和致残综合征(Nalbandian 等人,2021),这种综合征因患者而异,并且随着时间的推移而波动,这种症状被贴上了“长期症状”的不同标签。 COVID-19”、“COVID-19 急性后遗症”、“慢性 COVID-19”、“长途 COVID-19”或最新的“急性 COVID-19 综合症”术语。尽管对其开始期的定义尚未达成普遍共识,但关于该问题的最新 NICE 指南(国家健康与护理卓越研究所,2020)提出,对于持续出现症状的 COVID-19 和后 COVID-19 综合症,分别维持 4 周和 12 周的症状学时间跨度。最近的评论(Nalbandian 等人,2021)总结了最常见的临床症状:疲劳/肌肉无力和疼痛、呼吸困难、胸部
Frank Herbert, the renowned American science-fiction writer and author of the novel Dune, among others, once stated “There is no real ending. It’s just the place where you stop the story”. Recently, we as scientific community have come to learn that the meaning of this sentence can be of a special relevance among patients affected by COVID-19. Indeed, the discharge from a hospital setting, far from the end of the story, often represents just the beginning of the process.A constellation of both physical and mental symptoms can either continue or emerge in the afterwards, shaping a multisystemic and disabling syndrome ( Nalbandian et al., 2021) that varies from patient to patient and that fluctu-ates over time, which has been diversely labelled under the “Long COVID-19”,“Post-acute Sequelae of COVID-19”,“Chronic COVID-19”,“Long-hauler COVID-19” or the most recent “Post-Acute COVID-19 syndrome” terms. Although there is no universal consensus on the definition of its start period, last NICE guideline on the issue ( National Institute for Health and Care Excellence, 2020) proposes a 4-week and 12-week time span of maintained symptomatology for the ongoing symptomatic COVID-19 and the post-COVID-19-syndrome, respectively. Recent reviews ( Nalbandian et al., 2021) summarize the most frequently observed clinical pic-ture: fatigue/muscular weakness and ache, dyspnea, chest
DOI: 10.1016/j.euroneuro.2020.11.012
发表时间: 2021-01-01
影响因子: 5.6
作者:
Jagesar, Raj R.;Roozen, Mila C.;Vorstman, Jacob A. S.
通讯作者: Vorstman, Jacob A. S.
DOI: 10.1016/s2215-0366(20)30462-4
发表时间: 2021-03
期刊: The lancet. Psychiatry
影响因子: --
作者:
Taquet M;Luciano S;Geddes JR;Harrison PJ
通讯作者: Harrison PJ
DOI: 10.1016/j.euroneuro.2021.03.019
发表时间: 2021-05
期刊: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
影响因子: --
作者:
Miskowiak KW;Johnsen S;Sattler SM;Nielsen S;Kunalan K;Rungby J;Lapperre T;Porsberg CM
通讯作者: Porsberg CM
DOI: 10.1038/s41591-021-01283-z
发表时间: 2021-04
期刊: Nature medicine
影响因子: 82.9
作者:
Nalbandian A;Sehgal K;Gupta A;Madhavan MV;McGroder C;Stevens JS;Cook JR;Nordvig AS;Shalev D;Sehrawat TS;Ahluwalia N;Bikdeli B;Dietz D;Der-Nigoghossian C;Liyanage-Don N;Rosner GF;Bernstein EJ;Mohan S;Beckley AA;Seres DS;Choueiri TK;Uriel N;Ausiello JC;Accili D;Freedberg DE;Baldwin M;Schwartz A;Brodie D;Garcia CK;Elkind MSV;Connors JM;Bilezikian JP;Landry DW;Wan EY
通讯作者: Wan EY
DOI: 10.1007/s00259-021-05215-4
发表时间: 2021-08
影响因子: 9.1
作者:
Guedj E;Campion JY;Dudouet P;Kaphan E;Bregeon F;Tissot-Dupont H;Guis S;Barthelemy F;Habert P;Ceccaldi M;Million M;Raoult D;Cammilleri S;Eldin C
通讯作者: Eldin C